ALBIS to Distribute Arkema’s High-Performance Medical-Grade Polymers
ALBIS, one of the leading distributors of engineered and high-performance plastics, announces the addition of Arkema’s advanced polymers to its healthcare portfolio, with distribution to Europe, North Africa and the Middle East.
Arkema’s high-performance medical-grade materials meet stringent biocompatibility requirements, complying with USP Class VI and ISO 10993 regulations. They offer robust solutions designed for critical applications in healthcare – from minimally invasive medical devices to high-performance medical tubing and equipment. Known for their chemical resistance, flexibility and compliance with industry standards, these polymers meet the stringent requirements of healthcare manufacturers.
David Dupont, Vice President of Arkema’s Specialty Polyamides business, is enthusiastic about the collaboration, saying: “Through our partnership with ALBIS, our advanced materials are more accessible than ever before to support the growing needs and innovations in the healthcare market. ALBIS is renowned for its outstanding technical knowledge and service, and we look forward to a successful collaboration.”
Mike Freudenstein, Senior Marketing Director Healthcare and Industry Management at ALBIS, added: “We are very excited to add Arkema’s renowned brands to our healthcare portfolio. These high-performance medical-grade materials perfectly complement ALBIS’ existing offering: we can now offer even greater value to our customers in the healthcare sector by providing them with a more comprehensive portfolio of advanced polymers, including bio-based solutions.”
2026-08-21
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Arkema Triples Transparent Polyamide Capacity in Singapore: a Bet on Virtual Reality Growth or a Move to Strengthen Supply Resilience?
-
Arkema's New Singapore Plant Commences Operations, Tripling Polyamide Capacity
-
Arkema Divests PVC Additives Business to Focus Resources on High-Performance Materials Market
-
Arkema Invests $60 Million to Upgrade its US FluoroSpecialties Production Unit
-
Arkema Continues to Increase Investment in Singapore, Investing $20 Million to Build a Transparent Polyamide Plant
-
Arkema Receives ISCC PLUS Certification for Mass Balance of UV-LED-EB Resin Production
-
Arkema Announces Production of Bio-Based Performance Rheology Additives in Europe
-
Arkema Launches Acrylic Acid Purification Project
-
Arkema Invests $20 Million in North America to Increase PVDF Production Capacity by 15%
-
Bostik & Brückner Maschinenbau Collaborate on Peelable BOPET Lidding Film
Recommend Reading
-
Evonik Releases Financial Results Statement and Expects No Recovery in Global Chemical Market Demand in 2026
-
West Asia Tensions Squeeze Pharma Raw Materials
-
Aldi Expands Its Ingredient Ban
-
IPEC Updates Excipient Qualification Guidance
-
Pharmaceutical Tariffs Put Ingredients Back in Focus
-
This week, caustic soda prices were consolidating (March 2-6)
-
Geopolitical Conflicts Drive Major Increase in Styrene Prices
-
Polyethylene Prices Surge Across the Board, with High-Pressure Leading the Rise
-
Cost Hurricane: This Week, PET Bottle Chip Spot Prices Break Through the 7,000 CNY/ton Mark in China
-
Cost-driven Significant Increase in Acrylonitrile Prices in China